Founded in 2004 by physician-scientist Silviu Itescu, Mesoblast develops and manufactures allogeneic, off-the-shelf cellular medicines for severe inflammatory and tissue-damage conditions. Its proprietary mesenchymal lineage cell platform supports Ryoncil, the first FDA-approved mesenchymal stromal cell therapy, while the company advances additional therapies through operations in Australia, the United States and Singapore. Mesoblast’s manufacturing approach is designed for industrial-scale production of cryopreserved cell products without donor-recipient matching.
Innovative Cellular TherapeuticsHeadquartered in Rockville, Innovative Cellular Therapeutics is a private clinical-stage biotechnology company developing cellular immunotherapies for solid tumors. Its proprietary CoupledCAR® platform underpins individually made CAR-T therapies, including the lead GCC19CART program being studied for relapsed or refractory metastatic colorectal cancer. Founded by Larry Lei Xiao and Zoe Zhao Wu, ICT combines more than 20 years of stem-cell, cell-therapy and gene-editing experience with FDA cellular-therapy review expertise.ROCKVILLE, MD
STEMCELL TechnologiesFounded in 1993 by hematopoietic stem-cell researcher Dr. Allen Eaves, STEMCELL Technologies grew from his effort to produce standardized, cost-effective cell culture media into a global biotechnology company. Based in Vancouver and guided by its “Scientists Helping Scientists” ethos, the company supports life-science researchers worldwide with tools and expert assistance for cell-based research. Its quality management system is certified to ISO 13485:2016 and ISO 9001:2015.HARLEYSVILLE, PA
Rose BioSolutionsRose BioSolutions is an advanced therapy CDMO providing human immune and stem cells, biospecimens, plasmid DNA, viral vectors, and cell therapy manufacturing. Its integrated capabilities support research, process development, clinical manufacturing, and commercial production.
Minaris Advanced TherapiesBorn from the 2025 combination of Minaris Regenerative Medicine and WuXi Advanced Therapies, Minaris Advanced Therapies is a global contract development and manufacturing organization serving developers of cell and gene therapies. Its identity rests on a long technical lineage: more than 25 years in therapy manufacturing, over 40 years in advanced testing, and a history that includes producing the first GMP cell therapy lot in the United States in 2004. The company now supports programs from early development through commercial supply across facilities in North America, Europe and Asia.PHILADELPHIA, PA